| P50 | author | Jacques Guillot | Q48787034 |
| | Damien Dupont | Q57033699 |
| | Cédric Dananché | Q85635265 |
| P2093 | author name string | Philippe Vanhems | |
| | Françoise Botterel | |
| | Thomas Bénet | |
| | Marie-Paule Gustin | |
| | Martine Wallon | |
| | Laetitia Hénaff | |
| | Elise Melloul | |
| | Pierre Cassier | |
| | Sophie Tiphaine Loeffert | |
| P2860 | cites work | Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health | Q26999421 |
| | From the exposome to mechanistic understanding of chemical-induced adverse effects | Q28078152 |
| | Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation | Q28293483 |
| | Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works | Q30483839 |
| | Evaluation of hirst-type spore trap to monitor environmental fungal load in hospital. | Q33653237 |
| | Multiple-locus variable-number tandem repeat analysis for molecular typing of Aspergillus fumigatus. | Q33766853 |
| | PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. | Q34262338 |
| | Aspergillosis. Pathogenesis, clinical manifestations, and therapy | Q35038459 |
| | Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis | Q35273490 |
| | Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. | Q35528678 |
| | Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus. | Q35673582 |
| | Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. | Q35848799 |
| | Laboratory diagnosis of invasive aspergillosis. | Q36267587 |
| | Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 |
| | Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method | Q37538775 |
| | Challenges in microbiological diagnosis of invasive Aspergillus infections | Q37659157 |
| | Aspergillosis: nosocomial or community-acquired? | Q37785542 |
| | Azole resistant Aspergillus fumigatus: an emerging problem. | Q38096696 |
| | Indoor fungal contamination: health risks and measurement methods in hospitals, homes and workplaces | Q38099051 |
| | Azole resistance in Aspergillus fumigatus: a growing public health concern. | Q38152679 |
| | The clinical spectrum of pulmonary aspergillosis | Q38263687 |
| | Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation | Q38419604 |
| | Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment | Q38591628 |
| | Invasive aspergillosis: epidemiology and environmental study in haematology patients (Sfax, Tunisia). | Q39040642 |
| | Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis | Q40734608 |
| | High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. | Q40749403 |
| | Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France. | Q40887693 |
| | First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France. | Q41280441 |
| | Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles | Q41370116 |
| | Airborne Aspergillus and Penicillium in the atmosphere of Szczecin, (Poland) (2004-2009). | Q41997148 |
| | A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit | Q43908642 |
| | Airborne Aspergillus contamination during hospital construction works: efficacy of protective measures | Q43920986 |
| | Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit | Q44010583 |
| | Monitoring environmental Aspergillus spp. contamination and meteorological factors in a haematological unit | Q44024635 |
| | Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles | Q44157648 |
| | Microsatellite based typing of Aspergillus fumigatus: strengths, pitfalls and solutions. | Q44795768 |
| | Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. | Q45234796 |
| | Comparative evaluation of three impactor samplers for measuring airborne bacteria and fungi concentrations. | Q46017909 |
| | Interlaboratory reproducibility of a microsatellite-based typing assay for Aspergillus fumigatus through the use of allelic ladders: proof of concept | Q46166054 |
| | A 10-year survey of fungal aerocontamination in hospital corridors: a reliable sentinel to predict fungal exposure risk? | Q46903939 |
| | In vitro resistance of Aspergillus fumigatus to azole farm fungicide. | Q53803729 |
| | Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus. | Q54671391 |
| | Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007) | Q56838434 |
| | Usefulness of genotyping with microsatellite markers to investigate hospital-acquired invasive aspergillosis | Q56838518 |
| | Estimation of the incubation period of invasive aspergillosis by survival models in acute myeloid leukemia patients | Q57208469 |
| | Reduction of Invasive Aspergillosis Incidence among Immunocompromised Patients after Control of Environmental Exposure | Q57208477 |
| | Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study | Q57568519 |
| | Invasive aspergillosis | Q74492548 |
| | Invasive aspergillosis in critically ill patients without malignancy | Q80269940 |
| | Technical note: the effect of different incubation temperatures on the recovery of Aspergillus species from hospital air | Q84342715 |
| | [Quantitative assessment of fungal risk in the case of construction works in healthcare establishments: Proposed indicators for the determination of the impact of management precautions on the risk of fungal infection] | Q85519295 |
| P433 | issue | 11 | |
| P921 | main subject | aspergillosis | Q259626 |
| | invasive aspergillosis | Q3625278 |
| P304 | page(s) | e018109 | |
| P577 | publication date | 2017-11-25 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Monitoring of clinical strains and environmental fungal aerocontamination to prevent invasive aspergillosis infections in hospital during large deconstruction work: a protocol study | |
| P478 | volume | 7 | |